Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia

MeSH terms

• Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
• Humans
• Leukemia, Myeloid, Acute* / drug therapy
• Neoplasm, Residual
• Sulfonamides / therapeutic use